North America held the largest share in the global blood group typing market in 2016, followed by Europe. It was the prominent market for the blood group typing products and services.
Blood group typing is a procedure of determining what specific type of blood a person has, which depends on the presence of antigens on the red blood cells. It is done in organ donation process, to safely donate or receive a blood transfusion and to determine whether Rh factor is present on the surface of the red blood cell.
Blood group typing is very important during pregnancy as it can prevent severe anaemia in the new born. There are various techniques and methods to detect the blood group.
The global blood group typing market has witnessed significant growth due to the advancement in technology which has improved detection methods.
Explore Report at: www.psmarketresearch.com/market-analysis/blood-group-typing-market
The global blood group typing market is categorized on the basis of the product and service offerings; techniques used; type of tests; and its end users. Based on product and services, the global market is segmented into consumables, instruments and services.
Consumable, which includes blood bank saline, anti-human globulin reagents, antisera reagents and red blood cells reagents, held largest share in the global blood typing market in 2016. It has major contribution towards the growth of the global group typing market as compared to other segments.
The major factor driving this growth are increasing rate of blood donation and major surgical procedures like organ
Regulatory standards for the blood transfusion are stringent as it is a very crucial process. Stringent regulatory requirements hinder the growth of the global blood group typing market.
Other key factor restraining the growth of the global market is lack of trained and skilled professionals which can cause misleading transfusion.
In October 2016, Bio-Rad Laboratories, Inc., a manufacturer of life sciences and clinical diagnostic products, received the U.S. Food and Drug Administration (FDA) approval for its IH-1000 blood instrument.
In May 2014, Immucor’s PreciseType HEA Test received FDA approval to be used for screening blood donors for sickle cell trait (SCT). The PreciseType HEA test is the FDA-approved molecular assay designed to provide blood banks and clinicians with the detailed genetic matching information that they need to reduce the risk of alloimmunization and serious haemolytic reactions, which is especially problematic for patients receiving frequent blood transfusions.
Category: Market Research Publishers and RetailersCompany profile: PS Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research based consulting services across a range of industries. With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our pub ...
For more information:Make an Inquiry about this report HERE!